Moderna (NASDAQ:MRNA – Free Report) had its price objective decreased by Evercore ISI from $60.00 to $50.00 in a research ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

Research analysts at Leerink Partnrs issued their Q4 2025 earnings estimates for Moderna in a research note issued to ...

The human metapneumovirus (hMPV) is a common respiratory virus that typically causes mild cold-like symptoms. Studies show it has circulated in human populations since the 1970s, though it was ...

Kashmir's leading scientist and gastroenterologist, Prof M Sultran Khuroo writes about the evolution of the Human Metapneumovirus (HMPV) ...

HMPV Case Highlights: Over 15 cases of Human Metapneumovirus (HMPV) have been detected in different regions of India this season. Puducherry has reported three cases, while Gujarat has confirmed five.

The missive, released on Monday, is widely read in the biotech community where he has helped found dozens of companies, including Moderna. Combining human efforts, nature, and AI in what Afeyan ...

“Human Metapneumovirus (HMPV) is a common respiratory virus that causes an upper respiratory infection (like a cold). It is a seasonal disease that usually occurs in the winter and early spring ...

Shares of Moderna Inc. fell sharply on Monday after the biotech firm projected a steep decline in 2025 revenues, falling below Wall Street expectations. The company, known for its COVID-19 vaccine ...

But scientists at Moderna are in the late stages of testing what could be the first such shot, using mRNA technology against the virus. Here’s what to know about norovirus and where things stand ...

Antibiotics are ineffective against viral infections like human metapneumovirus (HMPV). HMPV affects the respiratory system, and antibiotics, designed to target bacteria, won't help. Misusing ...

The first cases of Human Metapneumovirus (HMPV) in the country have been confirmed in two infants. The virus is prevalent globally, with heightened vulnerability to infants, older adults ...